563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study

Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Schmidt H, Lenz G. Mesters R, Berdel WE (2020)
In: (eds.), ..
Type of Publication: Research article in edited proceedings (conference)

CD13-targetierte vaskuläre Infarzierung als experimentelle Therapie beim kleinzelligen Lungenkarzinom

Schmidt L, Stucke-Ring J, Brand C, Schliemann C, Harrach S, Muley T, Herpel E, Kessler T, Mohr M, Görlich D, others (2018)
In: 59. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V., Dresden, .
Type of Publication: Abstract in digital collection (conference)

Potential therapeutic impact of CD13 expression in non-small cell lung cancer

Schmidt LH, Brand C, Stucke-Ring J, Schliemann C, Kessler T, Harrach S, Mohr M, Görlich D, Marra A, Hillejan L, Müller-Tidow C, Lenz G, Wardelmann E, Wiewrodt R, Berdel WE, Schwöppe C, Hartmann W (2017)
In: PloS one, 12(6)
Type of Publication: Research article (journal)

Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients.

Liersch R, Gerss J, Schliemann C, Bayer M, Schwöppe C, Biermann C, Appelmann I, Kessler T, Löwenberg B, Büchner T, Hiddemann W, Müller-Tidow C, Berdel WE, Mesters R (2012)
In: Blood, 119(22)
Type of Publication: Research article (journal)

Tissue-factor fusion proteins induce occlusion of tumor vessels.

Schwöppe C, Kessler T, Persigehl T, Liersch R, Hintelmann H, Dreischalück J, Ring J, Bremer C, Heindel W, Mesters RM, Berdel WE (2010)
In: Thrombosis Research, 125 Suppl
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma Brand V, Greve B, Bölling T, Eich HT, Willich N, Harrach S, Hintelmann H, Lenz G, Mesters RM, Kessler T, Schliemann C, Berdel WE, Schwöppe C (2020) In: PloS one, 15(2) Type of Publication: Research article (journal)
563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Schmidt H, Lenz G. Mesters R, Berdel WE (2020) In: (eds.), .. Type of Publication: Research article in edited proceedings (conference)
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE (2020) In: Cancers, 12(6) Type of Publication: Research article (journal)
CD13-targetierte vaskuläre Infarzierung als experimentelle Therapie beim kleinzelligen Lungenkarzinom Schmidt L, Stucke-Ring J, Brand C, Schliemann C, Harrach S, Muley T, Herpel E, Kessler T, Mohr M, Görlich D, others (2018) In: 59. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V., Dresden, . Type of Publication: Abstract in digital collection (conference)
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer Schmidt LH, Stucke-Ring J, Brand C, Schliemann C, Harrach S, Muley T, Herpel E, Kessler T, Mohr M, Görlich D, Kreuter M, Lenz G, Wardelmann E, Thomas M, Berdel WE, Schwöppe C, Hartmann W (2017) In: Lung Cancer, 113 Type of Publication: Research article (journal)
Potential therapeutic impact of CD13 expression in non-small cell lung cancer Schmidt LH, Brand C, Stucke-Ring J, Schliemann C, Kessler T, Harrach S, Mohr M, Görlich D, Marra A, Hillejan L, Müller-Tidow C, Lenz G, Wardelmann E, Wiewrodt R, Berdel WE, Schwöppe C, Hartmann W (2017) In: PloS one, 12(6) Type of Publication: Research article (journal)
Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor. Liersch R, Shin JW, Bayer M, Schwöppe C, Schliemann C, Berdel WE, Mesters R, Detmar M (2012) In: International Journal of Oncology, 2012 Type of Publication: Research article (journal)
Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. Liersch R, Gerss J, Schliemann C, Bayer M, Schwöppe C, Biermann C, Appelmann I, Kessler T, Löwenberg B, Büchner T, Hiddemann W, Müller-Tidow C, Berdel WE, Mesters R (2012) In: Blood, 119(22) Type of Publication: Research article (journal)
Alternative targeting of Arabidopsis plastidic glucose-6-phosphate dehydrogenase G6PD1 involves cysteine-dependent interaction with G6PD4 in the cytosol. Meyer T, Hölscher C, Schwöppe C, von Schaewen A (2011) In: The Plant journal, 66(5) Type of Publication: Research article (journal)
Tissue-factor fusion proteins induce occlusion of tumor vessels. Schwöppe C, Kessler T, Persigehl T, Liersch R, Hintelmann H, Dreischalück J, Ring J, Bremer C, Heindel W, Mesters RM, Berdel WE (2010) In: Thrombosis Research, 125 Suppl Type of Publication: Research article (journal)